You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Details for Patent: 4,882,452


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,882,452
Title: Process for the preparation of ifosfamide having improved properties
Abstract:Ifosfamide having improved properties is obtained by crystallization from a solvent mixture selected from the group consisting of (a) a mixture of diethyl ether and a C.sub.1 -C.sub.3 alkanol or (b) a mixture of diisopropyl ether and a C.sub.1 -C.sub.3 alkanol under specific controlled conditions.
Inventor(s): Engel; Jurgen (Alzenau, DE), Muller; Siegfried (Bad Homburg, DE), Laubner; Werner (Halle, DE)
Assignee: Asta Pharma Akteingesellschaft (Frankfurt am Main, DE)
Application Number:07/163,586
Patent Claim Types:
see list of patent claims
Compound; Process; Formulation; Composition;
Patent landscape, scope, and claims:

United States Patent 4,882,452: A Detailed Analysis of Scope and Claims

Introduction

United States Patent 4,882,452, titled "Process for the preparation of ifosfamide having improved properties," is a significant patent in the field of pharmaceuticals, particularly in the synthesis and purification of ifosfamide, a chemotherapeutic agent. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background of Ifosfamide

Ifosfamide is a widely used anticancer drug, belonging to the class of alkylating agents. It is employed in the treatment of various types of cancers, including testicular cancer, ovarian cancer, and certain types of lymphoma. The quality and purity of ifosfamide are crucial for its therapeutic efficacy and safety.

Patent Overview

Publication Details

  • Patent Number: US 4,882,452
  • Publication Date: August 22, 1989
  • Assignee: Not specified in the provided source, but typically assigned to the inventors or their affiliated institutions/companies.
  • Inventors: The inventors are not specified in the provided source, but they are likely chemists or pharmaceutical researchers involved in the development of ifosfamide.

Scope of the Patent

The patent describes a process for preparing ifosfamide with improved properties, focusing on the crystallization method to enhance the drug's purity and stability.

Key Aspects of the Scope

  • Crystallization Method: The patent outlines a specific crystallization process using a solvent mixture. This method involves selecting solvents such as diethyl ether, diisopropyl ether, or methanol to achieve high-quality crystals of ifosfamide[1].
  • Improved Properties: The process aims to produce ifosfamide with improved properties, such as higher purity, better stability, and potentially enhanced therapeutic efficacy.
  • Process Steps: The patent details various steps including solution preparation, cooling, nucleation, stirring, and drying to ensure the formation of high-quality crystals.

Claims of the Patent

The claims of the patent are critical as they define the legal boundaries of the invention.

Independent Claims

  • The patent includes claims related to the specific method of crystallization, including the use of particular solvent mixtures and the conditions under which the crystallization is performed.
  • For example, Claim 1 might specify the process of crystallizing ifosfamide from a solution containing a mixture of diethyl ether and methanol under controlled temperature and stirring conditions[1].

Dependent Claims

  • Dependent claims further elaborate on the independent claims by specifying additional details such as the ratio of solvents, the temperature range, and the duration of the crystallization process.
  • These claims help to narrow down the scope and ensure that the invention is clearly defined and distinguishable from prior art.

Patent Landscape

Prior Art

The patent landscape for ifosfamide preparation involves a review of prior art related to the synthesis and purification of ifosfamide. The inventors would have conducted a thorough search to ensure their method was novel and non-obvious over existing techniques.

Related Patents

Other patents related to ifosfamide may cover different aspects such as synthesis routes, formulation methods, or specific applications. These patents would be part of the broader patent landscape and could influence the scope and validity of US 4,882,452.

International Patent Considerations

Ifosfamide is a globally used drug, and patents related to its preparation might be filed in various jurisdictions. The global patent landscape would include similar patents filed in other countries, which could affect the international validity and enforcement of US 4,882,452.

Practical Implications

Manufacturing and Quality Control

The patented process has significant implications for the manufacturing of ifosfamide. Pharmaceutical companies can use this method to ensure consistent quality and purity of the drug, which is critical for patient safety and therapeutic efficacy.

Regulatory Compliance

Regulatory bodies such as the FDA would require compliance with the patented process if it is the standard method for producing ifosfamide. This ensures that all manufactured batches meet the specified quality standards.

Legal and Policy Considerations

Patent Litigation

The scope and claims of the patent are crucial in patent litigation. Any infringement claims would need to be evaluated based on the specific language and boundaries set by the patent claims.

Patent Validity

The validity of the patent could be challenged based on prior art or obviousness. The examination process, as discussed in other patent studies, tends to narrow the scope of patent claims, ensuring that only novel and non-obvious inventions are granted[3].

Conclusion

United States Patent 4,882,452 is a significant contribution to the field of pharmaceuticals, particularly in the synthesis and purification of ifosfamide. The patent's scope and claims are carefully defined to ensure the production of high-quality ifosfamide, which is essential for its therapeutic use.

Key Takeaways

  • Crystallization Method: The patent describes a specific crystallization process using solvent mixtures to enhance the purity and stability of ifosfamide.
  • Improved Properties: The process aims to produce ifosfamide with improved properties, such as higher purity and better stability.
  • Legal and Practical Implications: The patent has significant implications for manufacturing, quality control, and regulatory compliance.
  • Patent Landscape: The patent is part of a broader landscape that includes prior art, related patents, and international considerations.

FAQs

What is the main focus of United States Patent 4,882,452?

The main focus of the patent is a process for preparing ifosfamide with improved properties through a specific crystallization method.

What solvents are used in the crystallization process described in the patent?

The patent specifies the use of solvents such as diethyl ether, diisopropyl ether, or methanol for the crystallization process.

Why is the purity of ifosfamide important?

The purity of ifosfamide is crucial for its therapeutic efficacy and patient safety, as impurities can affect the drug's performance and safety profile.

How does the patent impact the manufacturing of ifosfamide?

The patented process ensures consistent quality and purity of ifosfamide, which is critical for regulatory compliance and patient safety.

Can the validity of the patent be challenged?

Yes, the validity of the patent can be challenged based on prior art or obviousness, and the examination process tends to narrow the scope of patent claims to ensure novelty and non-obviousness.

Sources

  1. US4882452A - Process for the preparation of ifosfamide having improved properties - Google Patents
  2. U.S. Patent Small Claims Court - Administrative Conference of the United States
  3. Patent Claims and Patent Scope - SSRN
  4. Search for patents - USPTO - United States Patent and Trademark Office
  5. Report on Filing Patent/Trademark - United States Courts

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,882,452

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 4,882,452

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany3707154Mar 06, 1987

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.